Sigma Investment Counselors Inc Enlivex Therapeutics Ltd. Transaction History
Sigma Investment Counselors Inc
- $1.69 Billion
- Q4 2024
A detailed history of Sigma Investment Counselors Inc transactions in Enlivex Therapeutics Ltd. stock. As of the latest transaction made, Sigma Investment Counselors Inc holds 28,000 shares of ENLV stock, worth $29,680. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,000
Previous 30,000
6.67%
Holding current value
$29,680
Previous $50,000
36.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ENLV
# of Institutions
26Shares Held
2.59MCall Options Held
20.8KPut Options Held
3K-
Armistice Capital, LLC New York, NY2.14MShares$2.27 Million0.06% of portfolio
-
Morgan Stanley New York, NY246KShares$260,4990.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny74.8KShares$79,2760.0% of portfolio
-
Xtx Topco LTD London, X022.7KShares$24,0180.0% of portfolio
-
Act Capital Management, LLC Wayne, PA15KShares$15,9000.09% of portfolio
About Enlivex Therapeutics Ltd.
- Ticker ENLV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,403,200
- Market Cap $19.5M
- Description
- Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. Enlivex Therapeutics Ltd. was founded in 2...